Publications

5674 Results

Evaluating Serum Thymidine Kinase 1 (TK1) as a Prognostic and Predictive Marker in Estrogen Receptor (ER) Positive Metastatic Breast Cancer (MBC) Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial

Authors
C Paoletti;W Barlow;M Bergqvist;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, San Antonio TX), poster presentation, abst. PS2-04
Year
2020
Research Committee(s)
Breast
Study Number(s)
S0226

Dual Classification by Immune Response Signature and Homologous Recombination Deficiency Reveals Immune-Dependent and -Independent Prognostic Groups in patients with Triple Negative Breast Cancer (TNBC) treated with AC Chemotherapy (SWOG S9313)

Authors
S Stecklein;W Barlow;L Pusztai;TBA Myriad;TBA Almac;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation
Year
2020
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
K Kalinsky;W Barlow;F Meric-Bernstam;J Gralow;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;M Martin;M Gil Gil;C Arce-Salinas;E Brain;I Park;J-Y Pierga;A Lluch Hernandez;M Ramos Vazquez;M Ruiz Borrego;KH Jung;J-M Ferrero;A Schott;S Shak;P Sharma;DL Lew;J Miao;D Tripathy;G Hortobagyi;L Pusztai
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral presentation, abst. GS3-00
Year
2020
Research Committee(s)
Breast
Study Number(s)
S1007

Predictors of pain reduction in trials of interventions for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS)

Authors
NL Henry;J Unger;C Till;K Crew;M Fisch;D Hershman
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), Spotlight Poster-Discussion Session, abst # PD12-03
Year
2020
Research Committee(s)
Breast and Symptom Management and Survivorship
Study Number(s)
S0927, S1200, S1202

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Authors
S Zarnegar-Lumley;T Alonzo;M Othus;Z Sun;R Ries;Y Wang;A Leonti;M Kutney;D Stirewalt;J Radich;F Appelbaum;E Pogosova-Agadjanyan;K O'Dwyer;H Erba;O Abdel-Wahab;M Tallman;M Litzow;E Atallah;S Luger;R Levine;T Cooper;A Gamis;R Aplenc;A Kolb;S Meshinchi;K Tarlock
Journal / Conference
American Society of Hematology (December 5-8, 2020, San Diego, CA), oral, abst #388
Year
2020
Research Committee(s)
Leukemia
Study Number(s)
S0106

E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group

Authors
R Connolly;F Zhao;K Miller;M Lee;R Piekarz;K Smith;U Brown-Glaberman;J Winn;A Lyss;A Onitilo;M Burkard;G Budd;E Levine;M Royce;P Kaufman;A Thomas;J Trepel;A Wolff;J Sparano
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation, abst. GS402
Year
2020
Research Committee(s)
Breast
Study Number(s)
CTSU/E2112

Incidence and Prognostic Impact of Crh in Acute Myeloid Leukemia

Authors
M Othus;G Garcia-Manero;F Appelbaum;H Erba;E Estey
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Leukemia
Study Number(s)
S1203

Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Authors
A Rodday;S Parsons;C Scharman;R Advani;M Federico;J Friedberg;A Gallamini;D Hodgson;P Hoskin;M Hutchings;P Johnson;K Kelly;J Radford;P Luigi;J Cerhan;J Raemaekers;Holistic Consortium
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Local Review versus (vs) Central Review of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Diffuse Large B-Cell Lymphoma (DLBCL): Results from the CALGB 50303 Trial [Alliance]

Authors
A Ruppert;L Pederson;M Knopp;D Poon;J Zhang;B Kahl;JW Friedberg;L Schwartz;W Wilson;JP Leonard;N Bartlett;H Schoder
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma

SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Authors
A Herrera;H Li;S Castellino;S Rutherford;A Evens;K Davidson;A Punnett;L Constine;D Hodgson;S Parsons;A Prica;L Kostakoglu;M Shipp;M Leblanc;C Laubach;M Crump;B Kahl;JP Leonard;K Kelly;S Smith;JW Friedberg
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826